Original Research Open access Published: 28 Apr 2026
SGLT2 inhibitors and progression of moderate calcific aortic stenosis: Protocol for a prospective multicentre cohort study (SLOW-AS)
Klaus Weber, Eugene Braunwald, Walter E. Desai
- 1 TIMI Study Group, Division of Cardiology, Brigham and Women’s Hospital, Boston, Massachusetts, USA
- 2 Miller Family Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Journal of Experimental & Integrative Medicine volume 14 pages 11-20 (2026)
Cite this articleKeywords: Aortic stenosis; calcific aortic valve disease; SGLT2 inhibitors; disease progression; echocardiography; cardiac damage staging
Full text
Cite this article
Choose a citation format, then copy it into your reference manager or manuscript.
Weber, K., Braunwald, E. & Desai, W. E. SGLT2 inhibitors and progression of moderate calcific aortic stenosis: Protocol for a prospective multicentre cohort study (SLOW-AS). J. Exp. Integr. Med. 14, 11–20 (2026). https://www.jeim.org/articles/2614207